Concerns with antiepileptic drug initiation: Safety, tolerability and efficacy

被引:34
作者
Ferrendelli, JA [1 ]
机构
[1] Univ Texas, Sch Med, Dept Neurol, Houston, TX 77030 USA
关键词
antiepileptic drugs; drug initiation; tolerability;
D O I
10.1046/j.1528-1157.2001.0420s4028.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A number of commonly used antiepileptic drugs (AEDs) produce severe adverse effects if they are introduced at their usual daily maintenance doses. Gradual slow titration of the dose often avoids these adverse effects almost entirety. Conversely, some AEDs can be started at their effective maintenance dose and perhaps even with a loading dose. Although the mechanisms of these distinctions among antiepileptic compounds are poorly understood, the phenomenon clearly has important implications for the optimal use of the drugs, especially when rapid seizure control is desired. Examples of drugs that require gradual introduction are lamotrigine, carbamazepine, topiramate, tiagabine, and zonisamide. Phenytoin, oxcarbazepine, gabapentin, valproate, and levetiracetam are examples of drugs that can be started at an effective dose.
引用
收藏
页码:28 / 30
页数:3
相关论文
共 12 条
[1]   A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy [J].
Betts, T ;
Waegemans, T ;
Crawford, P .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2000, 9 (02) :80-87
[2]   Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial [J].
Cereghino, JJ ;
Biton, V ;
Abou-Khalil, B ;
Dreifuss, F ;
Gauer, LJ ;
Leppik, I .
NEUROLOGY, 2000, 55 (02) :236-242
[3]   Drug treatment of epilepsy [J].
Feely, M .
BRITISH MEDICAL JOURNAL, 1999, 318 (7176) :106-109
[4]   Rapid initiation of gabapentin - A randomized, controlled trial [J].
Fisher, RS ;
Sachdeo, RC ;
Pellock, J ;
Penovich, PE ;
Magnus, L ;
Bernstein, P .
NEUROLOGY, 2001, 56 (06) :743-748
[5]   Lamotrigine-associated rash: Risk benefit considerations in adults and children [J].
Guberman, AH ;
Besag, FMC ;
Brodie, MJ ;
Dooley, JM ;
Duchowny, MS ;
Pellock, JM ;
Richens, A ;
Stern, RS ;
Trevathan, E .
EPILEPSIA, 1999, 40 (07) :985-991
[6]  
LEPPIK IE, 1997, EPILEPSY Q, P5
[7]  
Marks WJ, 1998, AM FAM PHYSICIAN, V57, P1589
[8]  
*MED EC CO INC, 2001, PHYS DESK REF, P422
[9]   Rash in adult and pediatric patients treated with lamotrigine [J].
Messenheimer, JA .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1998, 25 (04) :S14-S18
[10]   Using topiramate in patients with epilepsy: Practical aspects [J].
Sander, JWAS .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1998, 25 (03) :S16-S18